Call For a Free Consultation 24/7 - Se Habla EspaƱol

Local Medical Center Announces Drug Recall

At the beginning of July the U.S. Food and Drug Administration announced a recall of several drug products that are used to treat high blood pressure, due to a potential cancer risk. These recalls have been linked to the active ingredient Valsartan.

McDonald Army Health Center (MCAHC) at Joint Base Langley-Eustis announced July 27, 2018 on its Facebook page that it was alerting the community about a voluntary recall of the blood pressure medication Valsartan and Hydrochlorothiazide combination tablets. Only the combination medication is affected.

Affected prescriptions include:


Valsartan/HCTZ 80/12.5mg tabs - PINK, OBLONG, HH, 345


Valsartan/HCTZ 80/12.5mg tabs - PEACH, OBLONG, VH1
Valsartan/HCTZ 160/12.5mg tabs - RED, OBLONG, VH2
Valsartan/HCTZ 160/25mg tabs - BROWN, OBLONG, VH3
Valsartan/HCTZ 320/12.5mg tabs - PINK, OBLONG, VH4
Valsartan/HCTZ 320/25mg tabs - YELLOW, OBLONG, VH5

If you received the Valsartan and Hydrochlorothiazide medication from any pharmacy, please take time to inspect your tablets. If you suspect they are one of the above-listed descriptions, please bring in your remaining tablets to the pharmacy that dispensed this to you to ensure that your medication is not affected. If you received the medication from MCAHC, please take the tablets to Health Center MAIN Pharmacy for replacement.

If you or a loved have been injured by a drug, please contact Kalfus & Nachman today or call (855) 880-8163to schedule a free case evaluation with one of our experienced defective drug attorneys. We represent defective drug victims throughout Norfolk, Hampton, Portsmouth, Roanoke, Virginia Beach, and Newport News, Virginia.

Related Posts
  • Defective 3M Military Earplugs Cause Hearing Injuries Read More
  • Honey Smacks Cereal Being Recalled Due to Salmonella Read More
  • Teething Products Linked to Drug Injuries Read More